Survival and fracture risk with radium-223 therapy in metastatic castrate-resistant prostate cancer (mCRPC): A real-world analysis.
Autor: | Zhang, Hanbo, Graham, Jeffrey, Czaykowski, Piotr, Gingerich, Joel Roger, Bybel, Bohdan, Dawe, David E |
---|---|
Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p50-50, 235p |
Databáze: | Supplemental Index |
Externí odkaz: |